{"brief_title": "Non-small Cell Lung Cancer Study US75 (Z-PACT)", "brief_summary": "This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.", "condition": ["Non Small Cell Lung Carcinoma"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["zoledronic acid", "Taxotere", "Carboplatin"], "arm_group_label": ["Zometa\u00ae", "Zometa\u00ae", "Zometa\u00ae"], "criteria": "Inclusion Criteria: - Male or Female patients at least of 18 years old - Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery - Women must not be pregnant or attempting to become pregnant - Able and willing to sign informed consent Exclusion Criteria: - Patients with cancer that has spread to the bone - Patients with cancer that has spread to the brain who are receiving treatment - Patients with kidney disease - Patients treated with other investigational drugs", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Bone Metastases", "mesh_term": ["Lung Neoplasms", "Carcinoma, Non-Small-Cell Lung", "Docetaxel", "Carboplatin", "Zoledronic acid"], "id": "NCT00086268"}